Sign up Australia
Proactive Investors - Run By Investors For Investors

iAnthus Capital upbeat on new Vermont bill, which expands medical pot program

If passed, Vermont's adult use cannabis market could potentially exceed US$100 million, according to one report.
iAnthus Capital upbeat on new Vermont bill, which expands medical pot program
The medical pot program has been expanded in Vermont with the S.16 bill

Cannabis-focused financier iAnthus Capital Holdings Inc (CSE:IAN, OTCQB:ITHUF) has welcomed latest legal changes in the state of Vermont, USA, which expands its medical marijuana program.

One Governor Scott has recently signed S.16 into law, which adds Crohn's Disease, Parkinson's Disease, and Post-Traumatic Stress Disorder to Vermont's list of qualifying conditions in the legalised market.

"While it is impossible to be certain that the state will revisit legalization of cannabis for adult use in the 2018 legislative session, Governor Scott has certainly expressed his willingness to work with lawmakers on this initiative, and I believe we are likely to see another adult use bill proposed in the next legislative session," Randy Maslow, the president of iAnthus, told investors.

If passed, Vermont's adult use cannabis market could potentially exceed US$100 million, according to  a report in 2015.

IAnthus is the sole provider of financing and management services to Grassroots Vermont - one of the four non-profit entities currently licensed to dispense medical cannabis to patients across the state. 

It has provided it with a credit facility of US$775,000.

This new law also allows Grassroots to expand its operations by opening an additional dispensary location, in addition to its existing one in Brandon.

"We support the efforts made by the state to make the medical cannabis program more accessible to Vermont's qualified patients," says Alex Ford, Executive Director of Grassroots.

"We look forward to securing our second dispensary location so that we can provide more patients with the highest quality, affordable medical cannabis."

During Vermont's 2017 legislative session, lawmakers also considered the legalization of cannabis for adult use.

While an adult use bill was passed by both the Vermont House and Senate, the bill was vetoed by the Governor, who nevertheless indicated a willingness to support adult use legislation in the future provided that certain concerns were addressed.

Shares eased 2.52% to $3.10. 

Why Invest In iAnthus? Read More Here

Register here to be notified of future IAN Company articles
View full IAN profile View Profile

iAnthus Timeline

Related Articles

September 15 2017
Legalised cannabis is the fastest growing industry in the US..
Internet TV specialsit Falcon Media House transformed and ready to start generating revenues
August 26 2017
It has gone from a cash shell to fully fledged online TV company plugged into a massive market in a year and half

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use